Market Place
Sourcing Support
Daiichi Sankyo discontinues development of Nafamostat in Japan
18 Jun 2021 //
BIOSPECTRUM ASIA
Daiichi Sankyo begins phase 1 trial in Japan for nafamostat inhalation formu
30 Mar 2021 //
PHARMABIZ
Chong Kun Dang proceeds to phase 2 trial in Russia to treat COVID-19
01 Sep 2020 //
KOREAN HERALD
The University of Tokyo, RIKEN, Nichi-Iko & Daiichi Sankyo ink R&D on nafamostat
08 Jun 2020 //
PHARMABIZ
Sun Pharma to trial Nafamostat for Covid-19 treatment
01 Jun 2020 //
CLINICALTRIALSARENA
Covid-19: Sun Pharma gets DCGI nod for nafamostat clinical trial in patients
29 May 2020 //
LIVEMINT
Korean researchers find drug that is more effective in treating COVID-19 than remdesivir
16 May 2020 //
PHARMAFILE
Univ. of Tokyo Starts Testing Avigan Plus Futhan for COVID-19
11 May 2020 //
PHARMA JAPAN
Ensysce, a California Based Biotech Company With a Mission to Solve the
15 Apr 2020 //
BIOSPACE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.